We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

189 hedge funds and large institutions have $941M invested in Meridian Bioscience Inc in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less funds holding

Funds holding: 215 → 189 (-26)

13% less capital invested

Capital invested by funds: $1.08B → $941M (-$136M)

14% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 73

39% less call options, than puts

Call options by funds: $5.92M | Put options by funds: $9.64M

55% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 47

Holders
189
Holders Change
-26
Holders Change %
-12.09%
% of All Funds
3.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
63
Reduced
73
Closed
47
Calls
$5.92M
Puts
$9.64M
Net Calls
-$3.73M
Net Calls Change
-$385K

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$25.9M
2
DM
Deerfield Management
New York
+$11.3M
3
BlackRock
BlackRock
New York
+$10.2M
4
FWIA
Fort Washington Investment Advisors
Ohio
+$9.39M
5
VLKIM
Van Lanschot Kempen Investment Management
Netherlands
+$8.79M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.3M
2
EARNEST Partners
EARNEST Partners
Georgia
-$9.67M
3
First Trust Advisors
First Trust Advisors
Illinois
-$3.65M
4
PFC
Phocas Financial Corp
California
-$3.54M
5
Goldman Sachs
Goldman Sachs
New York
-$3.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWA
176
TCI Wealth Advisors
Arizona
$3K +$700 +33 +38%
WQ
177
Wealth Quarterback
New Jersey
$3K +$2.44K +115 New
FPS
178
Fieldpoint Private Securities
Connecticut
$2K -$636 -30 -23%
CFGS
179
Concourse Financial Group Securities
Alabama
$2K -$191 -9 -9%
ACM
180
AUA Capital Management
Pennsylvania
$2K -$148 -7 -6%
PFGIA
181
Patriot Financial Group Insurance Agency
Massachusetts
$2K – – –
PFBT
182
Parkside Financial Bank & Trust
Missouri
$2K +$21 +1 +1%
QCG
183
Quadrant Capital Group
Ohio
$2K +$212 +10 +13%
CWC
184
Carolinas Wealth Consulting
North Carolina
$2K +$1.95K +92 +613%
OSAM
185
O'Shaughnessy Asset Management
Connecticut
$1K -$551 -26 -30%
HR
186
Howe & Rusling
New York
$1K +$1.12K +53 New
PCH
187
Polar Capital Holdings
United Kingdom
$892 – – –
AIG
188
American International Group
New York
$616 -$10.8K -510 -2%
Nisa Investment Advisors
189
Nisa Investment Advisors
Missouri
$395 -$70K -3,300 -16%
First Trust Advisors
190
First Trust Advisors
Illinois
– -$3.65M -139,157 Closed
PFC
191
Phocas Financial Corp
California
– -$3.54M -134,740 Closed
California Public Employees Retirement System
192
California Public Employees Retirement System
California
– -$2.26M -86,200 Closed
MSL
193
Mackay Shields LLC
New York
– -$2M -76,312 Closed
Creative Planning
194
Creative Planning
Kansas
– -$1.68M -64,044 Closed
JCIA
195
Jackson Creek Investment Advisors
Colorado
– -$1.26M -48,122 Closed
SBIA
196
Sheaff Brock Investment Advisors
Indiana
– -$1.09M -41,454 Closed
WAM
197
Wakefield Asset Management
Colorado
– -$920K -35,058 Closed
NA
198
Navellier & Associates
Nevada
– -$763K -29,068 Closed
CI Investments Inc
199
CI Investments Inc
Ontario, Canada
– -$680K -25,894 Closed
CAM
200
ClariVest Asset Management
California
– -$638K -24,300 Closed
6 7
8
9 10

VIVO Hedge Fund Activity: Q2 2021 in Review

189 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2021, worth a combined $941M — down 13% from $1.08B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of VIVO and 21 opened new positions — a net loss of 26 holders — while 73 trimmed existing stakes and 63 added.

The largest buyer was Royce & Associates, adding an estimated $25.9M. The largest seller was Fidelity Investments, cutting an estimated $10.3M.

  • 189 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2021, down from 215 in Q1 2021.
  • Funds reported $941M of Meridian Bioscience Inc stock for Q2 2021, down 13% quarter-over-quarter.
  • 21 funds opened new Meridian Bioscience Inc positions in Q2 2021 and 47 closed out, a net change of -26 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2021 was Royce & Associates, an estimated $25.9M added.
  • The largest Meridian Bioscience Inc seller in Q2 2021 was Fidelity Investments, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2021.